STAAR Surgical Company (STAA)
Upgrades & Downgrades
Latest STAA news
STAAR Surgical Company (STAA) Q3 2023 Earnings Call Transcript
1 November 2023
STAAR Surgical Company (NASDAQ:STAA ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Brian Moore - Vice President-Investor Relations & Corporate Development Tom Frin...
These healthcare stocks should come to life as boomers live their golden years
25 October 2023
Baby boomers: Love ‘em or hate ‘em, the juggernaut generation changes every aspect of life it steamrolls through. Now it's doing the same to healthcare.
STAAR Surgical: Not In My Sight Yet
24 October 2023
STAAR Surgical Company has developed the EVO ICL Lens to treat nearsightedness, offering clear vision without the hassle of contact lenses or glasses. The EVO ICL Lens has gained market share, with th...
STAAR Surgical: Economic Realities Beginning To Surface, Reiterate Hold
9 August 2023
STAAR Surgical Company's Q2 FY'23 earnings missed consensus estimates. The key revenue driver for STAA is its Implantable Collamer Lenses, which saw a 21% YoY increase in unit volumes. Despite potenti...
STAAR Surgical to Participate in Upcoming Investor Conferences
7 August 2023
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that management will part...
3 ‘Strong Buy' Growth Stocks You Should Be Loading Up On Now
7 August 2023
Growth stocks are on a tear this year, and while some names will inevitably cool off in the coming weeks, opportunities will always exist. In my opinion, investors should start taking profits from gro...
Staar Surgical (STAA) Q2 Earnings Beat Estimates
2 August 2023
Staar Surgical (STAA) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.42 per share a year ago.
STAAR Surgical to Report Second Quarter Results on August 2, 2023
19 July 2023
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release fina...
I See Opportunity In STAAR Surgical
26 May 2023
STAAR Surgical is on the cusp of an acceleration in earnings and growth courtesy of its entrance into the US market. It is profitable, generates positive cash flow, and has zero real debt.